Ocular Therapeutix Inc (0OT.SG)
Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
At close: 05:30PM CET
| Previous close | 4.3580 |
| Open | 4.4490 |
| Bid | 4.3250 x N/A |
| Ask | 4.8360 x N/A |
| Day's range | 4.4300 - 4.4950 |
| 52-week range | 2.4160 - 6.3040 |
| Volume | |
| Avg. volume | 81 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 08 May 2023 - 12 May 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
What Makes Ocular Therapeutix (OCUL) a Good Fit for 'Trend Investing'
Ocular Therapeutix (OCUL) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
- Simply Wall St.
Ocular Therapeutix Full Year 2022 Earnings: Revenues Beat Expectations, EPS Lags
Ocular Therapeutix ( NASDAQ:OCUL ) Full Year 2022 Results Key Financial Results Revenue: US$51.5m (up 18% from FY...
- Zacks
Ocular Therapeutix (OCUL) Reports Q4 Loss, Tops Revenue Estimates
Ocular Therapeutix (OCUL) delivered earnings and revenue surprises of 4% and 3.50%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
© 2023 Yahoo. All rights reserved.
